These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 5527012)

  • 21. Adriamycin (NSC-123127) and its analogs.
    Henry DW
    Cancer Chemother Rep 2; 1974 Dec; 4(4):5-9. PubMed ID: 4451911
    [No Abstract]   [Full Text] [Related]  

  • 22. Modification of transplantability and tumor growth following treatment of L1210 leukemia and TA3Ha cells with macromomycin (NSC-170105).
    Lippman MM; Abbott BJ
    Cancer Chemother Rep; 1973; 57(4):501-3. PubMed ID: 4762442
    [No Abstract]   [Full Text] [Related]  

  • 23. Anthracycline antibiotics with high liposome entrapment: structural features and biological activity.
    Perez-Soler R; Priebe W
    Cancer Res; 1990 Jul; 50(14):4260-6. PubMed ID: 2194651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new antitumor antimetabolite, (alphaS,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (NSC-163501): antimicrobial reversal studies and preliminary evaluation against L1210 mouse leukemia in vivo.
    Hanka LJ; Martin DG; Neil GL
    Cancer Chemother Rep; 1973 Apr; 57(2):141-8. PubMed ID: 4200486
    [No Abstract]   [Full Text] [Related]  

  • 25. [Rubidomycin-daunomycin therapy in acute myeloblastic leukemia].
    Dano K; Nissen NI; Pedersen-Bjergaard J; Thiede T
    Nord Med; 1968 Oct; 80(44):1475-82. PubMed ID: 5247180
    [No Abstract]   [Full Text] [Related]  

  • 26. Antitumor activity of new anthracycline antibiotics, aclacinomycin-A and its analogs, and their toxicity.
    Hori S; Shirai M; Hirano S; Oki T; Inui T; Tsukagoshi S; Ishizuka M; Takeuchi T; Umezawa H
    Gan; 1977 Oct; 68(5):685-90. PubMed ID: 579346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Azotomycin (NSC-56654)--clinical brochure.
    Carter SK
    Cancer Chemother Rep 3; 1968 Dec; 1(1):207-17. PubMed ID: 4917775
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. X.
    Kline I; Gang M; Tyrer DD; Venditti JM; Artis EW; Goldin A
    Cancer Chemother Rep 2; 1972 Nov; 3(1):1-69. PubMed ID: 4660732
    [No Abstract]   [Full Text] [Related]  

  • 29. Adriamycin analogues. Novel anomeric ribofuranoside analogues of daunorubicin.
    Israel M; Airey JE; Murray RJ; Gillard JW
    J Med Chem; 1982 Jan; 25(1):28-31. PubMed ID: 7086818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Daunomycin- and adriamycin-N-(2-hydroxypropyl)methacrylamide copolymer conjugates; toxicity reduction by improved drug-delivery.
    Seymour LW; Duncan R; Kopecková P; Kopecek J
    Cancer Treat Rev; 1987 Dec; 14(3-4):319-27. PubMed ID: 3326668
    [No Abstract]   [Full Text] [Related]  

  • 31. [Chemotherapy of L1210 leukemia: comparison of 7 drugs given either continuously for 20 days, or in a single massive dose, early or late].
    Mathé G; Schwarzenberg L; Hayat M; Schneider M
    Rev Fr Etud Clin Biol; 1968 Dec; 13(10):951-60. PubMed ID: 5306738
    [No Abstract]   [Full Text] [Related]  

  • 32. NeXstar Pharmaceuticals lauches DaunoXome.
    J Int Assoc Physicians AIDS Care; 1996 Jun; 2(6):52. PubMed ID: 11363700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Schedule-dependent synergism for the combination of 1-beta-D-arabinofuranosylcytosine and daunorubicin.
    Edelstein M; Vietti T; Valeriote F
    Cancer Res; 1974 Feb; 34(2):293-7. PubMed ID: 4810905
    [No Abstract]   [Full Text] [Related]  

  • 34. Adriamycin, an antitumour antibiotic: a review with special reference to daunomycin.
    Skovsgaard T; Nissen NI
    Dan Med Bull; 1975 Feb; 22(2):62-73. PubMed ID: 1093818
    [No Abstract]   [Full Text] [Related]  

  • 35. Observations on toxicity and clinical trials with daunomycin.
    Serpick AA; Henderson ES
    Pathol Biol; 1967 Oct; 15(19):909-12. PubMed ID: 4967536
    [No Abstract]   [Full Text] [Related]  

  • 36. On the reported lack of effectiveness of daunomycin (NSC-82151) and adriamycin (NSC-123127) on solid tumors.
    Lenaz L; Di Marco A
    Cancer Chemother Rep; 1972 Aug; 56(4):431-2. PubMed ID: 5081585
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies with 2,5-piperazinedione, 3,6-bis(5-chloro-2-piperidyl)-,dihydrochloride. III. Biochemical and therapeutic effects in L1210 leukemias sensitive and resistant to alkylating agents: comparison with melphalan, cyclophosphamide, and BCNU.
    Schabel FM; Trader MW; Laster WR; Shaddix SC; Brockman RW
    Cancer Treat Rep; 1976 Sep; 60(9):1325-33. PubMed ID: 1016968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative biochemical studies of adriamycin and daunomycin in leukemic cells.
    Wang JJ; Chervinsky DS; Rosen JM
    Cancer Res; 1972 Mar; 32(3):511-5. PubMed ID: 5061305
    [No Abstract]   [Full Text] [Related]  

  • 39. Novel mode of cytotoxicity obtained by coupling inactive anthracycline to a polymer.
    Rogers KE; Tökés ZA
    Biochem Pharmacol; 1984 Feb; 33(4):605-8. PubMed ID: 6422950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer chemotherapy. Studies on anticancer agents particularly anticancer antibiotics.
    Hata T
    Kitasato Arch Exp Med; 1971 Dec; 44(3):135-54. PubMed ID: 5155554
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.